year 17, Issue 1 (January - February 2023)                   Iran J Med Microbiol 2023, 17(1): 117-122 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fattahi Bafghi A, Minoo Sepehr M, Mozayan M R, Bagheri P, Dehghani A, Rezaee E. Passive Case Findings on Malaria in Yazd as a Central Province of Iran During 2011-2020. Iran J Med Microbiol 2023; 17 (1) :117-122
URL: http://ijmm.ir/article-1-1601-en.html
1- Department of Parasitology and Mycology, Infectious Diseases Research Center, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- Infectious Diseases Department of Yazd Health Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
3- General Courses Department, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4- Department of Hematology and Blood Banking, Paramedical School, Gerash University of Medical Sciences, Gerash, Iran
5- Biostatics and Epidemiology Department, School of Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
6- Department of Medical Parasitology and Mycology, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran , Rezaee.para92@gmail.com
Abstract:   (1143 Views)

Background and Aim: Malaria is considered one of the most serious life-threatening diseases in Yazd, a central province of Iran, which hosts both domestic and foreign immigrants. This study aimed to investigate the trend of Malaria in Yazd during 2011-2020.
Materials and Methods: In this descriptive retrospective study, all episodes of the disease (imported malaria) recorded at Yazd health center in Iran were carefully evaluated and reported. After preparing the peripheral blood smear and fixation with methanol, it was stained with Giemsa and examined with a light microscope by a skilled technician.
Results & Conclusion: Totally, 95 confirmed malaria patients were investigated from 2011 to 2020. Plasmodium falciparum was the predominant species with 81 cases (85.26%). The highest rate of infection was observed in 49 cases (51.6.3%), in the age group of 50 years with 27 cases (42.86%), and in the working class with 69 cases (72.63%). Despite a decrease in Malaria cases through the implementation of the eradication program compared to the last two decades, its imported type is still showing up in the country, especially in the cosmopolitan city of Yazd, where domestic and foreign workers and tourists usually travel; thus it requires to be further monitored and controlled.

Full-Text [PDF 517 kb]   (450 Downloads) |   |   Full-Text (HTML)  (324 Views)  
Type of Study: Brief Original Article | Subject: Medical Parasitology
Received: 2022/01/9 | Accepted: 2022/07/13 | ePublished: 2023/01/20

References
1. Bafghi AF, Pourmazar S, Shamsi F. Five-Year Status of Malaria (a Disease Causing Anemia) in Yazd, 2008-2012. Iran J Pediatr Hematol Oncol. 2013;3(3):91.
2. Sillehu S, Rumaolat W, Cahyawati S, Utami TN, Kartika D, Rina W. Malaria Prevention and Eradication Program Towards Malaria-Elimination in West-Seram. Indian J Forensic Med Toxicol. 2020;14(2).
3. Yang Y, Liu Y, Xie Z, Wu S, Yang L, Li W, et al. Epidemiology of malaria in Yulin, South China 1999-2016: Imported Malaria threatens zero local case status. Vector Borne Zoonotic Dis. 2018;18(10):533-8. [DOI:10.1089/vbz.2017.2236] [PMID]
4. Cibulskis RE, Alonso P, Aponte J, Aregawi M, Barrette A, Bergeron L, et al. Malaria: global progress 2000-2015 and future challenges. Infect Dis Poverty. 2016;5(1):1-8. [DOI:10.1186/s40249-016-0151-8] [PMID] [PMCID]
5. Thellier M, Simard F, Musset L, Cot M, Velut G, Kendjo E, et al. Changes in malaria epidemiology in France and worldwide, 2000-2015. Med Mal Infect. 2020;50(2):99-112. [DOI:10.1016/j.medmal.2019.06.002] [PMID]
6. CS B, Lokossou V, Landier J, Sylla B, Tougri G, Ouedraogo B, et al. Geo-epidemiology of Malaria in Burkina Faso, 2013-2018: a recent re-increase. 2021.
7. Organization WH. World malaria report 2020: 20 years of global progress and challenges. 2020.
8. Vatandoost H, Raeisi A, Saghafipour A, Nikpour F, Nejati J. Malaria situation in Iran: 2002-2017. Malar J. 2019;18(1):1-7. [DOI:10.1186/s12936-019-2836-5] [PMID] [PMCID]
9. Nejati J, Tabatabaei SM, Salehi M, Saghafipour A, Mozafari E. Some probable factors affecting the malaria situation before and at the beginning of a pre-elimination program in southeastern Iran. J Parasit Dis. 2017;41(2):503-9. [DOI:10.1007/s12639-016-0838-6] [PMID] [PMCID]
10. Azizi H, Davtalab-Esmaeili E, Farahbakhsh M, Zeinolabedini M, Mirzaei Y, Mirzapour M. Malaria situation in a clear area of Iran: an approach for the better understanding of the health service providers' readiness and challenges for malaria elimination in clear areas. Malar J. 2020;19(1):1-10. [DOI:10.1186/s12936-020-03188-7] [PMID] [PMCID]
11. Hassanpour G, Mohebali M, Zeraati H, Raeisi A, Keshavarz H. Asymptomatic malaria and its challenges in the malaria elimination program in Iran: a systematic review. J Arthropod Borne Dis. 2017;11(2):172.
12. Bruneel F. Human cerebral malaria: 2019 mini review. Rev Neurol. 2019;175(7-8):445-50. [DOI:10.1016/j.neurol.2019.07.008] [PMID]
13. Khalili MB, Anvari-Tafti M, Sadeh M. Epidemiological pattern of malarial disease in the province of Yazd, Iran (Since 1986-2006). World J Med Sci. 2009;4(1):41-5.
14. Rathore D, McCutchan TF, Sullivan M, Kumar S. Antimalarial drugs: current status and new developments. Expert Opin Investig Drugs. 2005;14(7):871-83. [DOI:10.1517/13543784.14.7.871] [PMID]
15. EDRISIAN GH. Malaria in Iran: Past and present situation. Iran J Parasitol. 2006;1(1).
16. Khan H, Khattak AM. A study of prevalence of malaria in adult population of DI Khan, Pakistan. Biomedica. 2006;22(14):99-104.
17. Sheikh AS, Sheikh AA, Sheikh NS, Paracha SM. Endemicity of malaria in Quetta. Pak J Med Res. 2005;44(1):41-50.
18. Yang D, Xu C, Wang J, Zhao Y. Spatiotemporal epidemic characteristics and risk factor analysis of malaria in Yunnan Province, China. BMC public health. 2017;17(1):1-10. [DOI:10.1186/s12889-016-3994-9] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc